These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31444600)
1. Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL). Coyne KS; Harrington A; Currie BM; Chen J; Gillard P; Spies JB J Patient Rep Outcomes; 2019 Aug; 3(1):57. PubMed ID: 31444600 [TBL] [Abstract][Full Text] [Related]
2. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082 [TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial. Lukes AS; Soper D; Harrington A; Sniukiene V; Mo Y; Gillard P; Shulman L Obstet Gynecol; 2019 May; 133(5):869-878. PubMed ID: 30969201 [TBL] [Abstract][Full Text] [Related]
4. Validity and Reliability of The Persian Version of Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire: A Psychometric Study. Najafiarab H; Keyvanfar A; Rahimi Mansour F; Didar H; Hooshmand Chayijan SH; Rajaei Firouzabadi SH; Hosseini MS; Bakhtiyari Z; Farzaneh F Int J Fertil Steril; 2023 Nov; 18(1):60-66. PubMed ID: 38041461 [TBL] [Abstract][Full Text] [Related]
5. Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study. Keizer AL; van Kesteren PJM; Terwee C; de Lange ME; Hehenkamp WJK; Kok HS BMJ Open; 2021 Nov; 11(11):e052664. PubMed ID: 34815284 [TBL] [Abstract][Full Text] [Related]
6. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Coyne KS; Margolis MK; Bradley LD; Guido R; Maxwell GL; Spies JB Value Health; 2012 Jan; 15(1):135-42. PubMed ID: 22264981 [TBL] [Abstract][Full Text] [Related]
8. Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language. Oliveira Brito LG; Malzone-Lott DA; Sandoval Fagundes MF; Magnani PS; Fernandes Arouca MA; Poli-Neto OB; Nogueira AA Sao Paulo Med J; 2017; 135(2):107-115. PubMed ID: 28301630 [TBL] [Abstract][Full Text] [Related]
9. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871 [TBL] [Abstract][Full Text] [Related]
10. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Coyne KS; Margolis MK; Murphy J; Spies J Value Health; 2012; 15(5):674-9. PubMed ID: 22867776 [TBL] [Abstract][Full Text] [Related]
11. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Harding G; Coyne KS; Thompson CL; Spies JB Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505 [TBL] [Abstract][Full Text] [Related]
12. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study. Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639 [TBL] [Abstract][Full Text] [Related]
13. Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid. Xu W; Chen W; Chen J; Hu L; Su X; Nie Y; Shi Q BMC Womens Health; 2022 Sep; 22(1):372. PubMed ID: 36088381 [TBL] [Abstract][Full Text] [Related]
14. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey. Soliman AM; Margolis MK; Castelli-Haley J; Fuldeore MJ; Owens CD; Coyne KS Curr Med Res Opin; 2017 Nov; 33(11):1971-1978. PubMed ID: 28836862 [TBL] [Abstract][Full Text] [Related]
15. Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL) questionnaire in women with uterine myomatosis. Calaf J; Palacios S; Cristóbal I; Cañete ML; Monleón J; Fernández J; Hernández A; Vázquez F Med Clin (Barc); 2020 Mar; 154(6):207-213. PubMed ID: 31685223 [TBL] [Abstract][Full Text] [Related]
16. [Validation of the Chinese version of the uterine fibroid symptom and health-related quality of life]. Wang XQ; Zhu L; Xu T; Zhang L; Lyu T; Chen R Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):455-460. PubMed ID: 28797152 [No Abstract] [Full Text] [Related]
17. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Spies JB; Coyne K; Guaou Guaou N; Boyle D; Skyrnarz-Murphy K; Gonzalves SM Obstet Gynecol; 2002 Feb; 99(2):290-300. PubMed ID: 11814511 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients' quality of life: a randomized clinical trial. Tam T; Juarez L BMC Womens Health; 2023 Oct; 23(1):541. PubMed ID: 37848865 [TBL] [Abstract][Full Text] [Related]
19. Burden of symptomatic uterine fibroids in Canadian women: a cohort study. Laberge PY; Vilos GA; Vilos AG; Janiszewski PM Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364 [TBL] [Abstract][Full Text] [Related]
20. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Brölmann H; Bongers M; Garza-Leal JG; Gupta J; Veersema S; Quartero R; Toub D Gynecol Surg; 2016; 13():27-35. PubMed ID: 26918001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]